Location: Castle Rauischholzhausen, Germany. First mentioned in 750 AD, the site was sold in 1873 to German diplomat and industrialist Ferdinand von Stumm, who competed with his brothers to build the most beautiful castle.
Date: Aug 31-Sep 03, 2015
Size: 30 invited attendees, feeding significant “live” social media outreach
Mission: To devise and implement ten new initiatives, across the development pipeline, for implementation in the following 12 months.
Launch concrete initiatives to discover, develop, and commercialize medicines for the most pressing needs in our society through the use of open and inclusive research models.
Forge: The first-ever global conference on open source pharma. Many of the players have never met. Create ties, form community, and forge alliances.
Learn: What does open source pharma mean? How does it relate to current, alternative pharma approaches? What is happening in the open source pharma field, and what is its applicability/potential at each stage of the pipeline?
Act: Explore and develop concrete projects and paths forward:
Urmi Bajpai – Delhi University
Manica Balasegaram – Médecins Sans Frontières
Jörg Bentzien – Boehringer-Ingelheim Pharmaceuticals
Samir Brahmachari – Open Source Drug Discovery
Sarah Dennis – McGill University
Robert Don – Drugs for Neglected Diseases Initiative
UC Jaleel – Open Source Drug Discovery
Peter Kolb – University of Marburg
John McKew – National Institutes of Health
Jaykumar Menon – McGill University
Bernard Munos – InnoThink and FasterCures
Ganesh Neelam – Sir Ratan Tata Trust
Sherwood Neiss – Crowdfund Capital Advisors
Piero Olliaro – World Health Organization
Melinda Richter – Janssen Labs/Johnson & Johnson
Tomasz Sablinski – Transparency Life Sciences
Zakir Thomas - Open innovation expert
Matthew Todd – University of Sydney and Open Source Malaria
Els Torreele – Open Society Foundations
Dimitrios Tzalis - European Lead Federation
John Wilbanks – Sage Bionetworks